IL-10 was considered as a switch from tumor-promoting inflammation to antitumor immunity, and deficient IL-10 signaling developed tumors spontaneously and at high rates (Oft, 2014; Talero et al., 2016). This evidence concerns the gene IL10 and neoplasm.